What is GeneDx Holdings's cumulative cost basis?

GeneDx Holdings (WGS) reported cumulative cost basis of $78.41M in Q1 2026.

What is the long-term trend for GeneDx Holdings's cumulative cost basis?

Over 2 years (2021 to 2025), GeneDx Holdings's cumulative cost basis has grown at a -21.2% compound annual growth rate (CAGR), from $114.63M to $71.21M.

GeneDx Holdings WGS Cumulative Cost Basis

Cumulative Cost Basis at other companies

Natera, Inc.NTRA

——

Tempus AI, Inc.TEM

——

Bio-Rad LaboratoriesBIO

——

Twist Bioscience CorporationTWST

——

AbbottABT

——

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.89B-24.3%

Enterprise value$1.89B-22.8%

P/S4.3×-3.3×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's cumulative cost basis?: GeneDx Holdings (WGS) reported cumulative cost basis of $78.41M in Q1 2026.
What is the long-term trend for GeneDx Holdings's cumulative cost basis?: Over 2 years (2021 to 2025), GeneDx Holdings's cumulative cost basis has grown at a -21.2% compound annual growth rate (CAGR), from $114.63M to $71.21M.